DK3774745T3 - CRYSTAL OF AN OXAZOLE COMPOUND - Google Patents

CRYSTAL OF AN OXAZOLE COMPOUND Download PDF

Info

Publication number
DK3774745T3
DK3774745T3 DK19718465.8T DK19718465T DK3774745T3 DK 3774745 T3 DK3774745 T3 DK 3774745T3 DK 19718465 T DK19718465 T DK 19718465T DK 3774745 T3 DK3774745 T3 DK 3774745T3
Authority
DK
Denmark
Prior art keywords
crystal
oxazole compound
oxazole
compound
Prior art date
Application number
DK19718465.8T
Other languages
Danish (da)
Inventor
Naohiko Kanai
Takayuki Yasutomi
Ryosuke Hirota
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of DK3774745T3 publication Critical patent/DK3774745T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK19718465.8T 2018-04-04 2019-04-03 CRYSTAL OF AN OXAZOLE COMPOUND DK3774745T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018072717 2018-04-04
PCT/JP2019/014730 WO2019194211A1 (en) 2018-04-04 2019-04-03 Oxazole compound crystal

Publications (1)

Publication Number Publication Date
DK3774745T3 true DK3774745T3 (en) 2024-06-17

Family

ID=66223774

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19718465.8T DK3774745T3 (en) 2018-04-04 2019-04-03 CRYSTAL OF AN OXAZOLE COMPOUND

Country Status (20)

Country Link
US (3) US11414391B2 (en)
EP (2) EP3774745B1 (en)
JP (3) JP7326295B2 (en)
KR (1) KR20200139736A (en)
CN (1) CN111902402A (en)
AU (1) AU2019249562B2 (en)
BR (1) BR112020019377A2 (en)
CA (1) CA3095866A1 (en)
DK (1) DK3774745T3 (en)
EA (1) EA202092393A1 (en)
FI (1) FI3774745T3 (en)
IL (1) IL277730A (en)
LT (1) LT3774745T (en)
MX (1) MX2020010435A (en)
PH (1) PH12020551605A1 (en)
PT (1) PT3774745T (en)
SG (1) SG11202009564TA (en)
TW (1) TW202012380A (en)
WO (1) WO2019194211A1 (en)
ZA (1) ZA202006134B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1954684T1 (en) 2005-11-15 2014-07-31 Otsuka Pharmaceutical Co., Ltd. Oxazole compound and pharmaceutical composition
EP2890686B1 (en) 2012-08-30 2017-01-04 Otsuka Pharmaceutical Co., Ltd. Method for producing oxazole compound
TWI726027B (en) 2015-12-28 2021-05-01 日商大塚製藥股份有限公司 Ointment

Also Published As

Publication number Publication date
US20240076275A1 (en) 2024-03-07
AU2019249562B2 (en) 2024-06-27
TW202012380A (en) 2020-04-01
JP2024001115A (en) 2024-01-09
EP3774745A1 (en) 2021-02-17
FI3774745T3 (en) 2024-06-19
LT3774745T (en) 2024-07-10
JP7326295B2 (en) 2023-08-15
AU2019249562A1 (en) 2020-10-22
EP4400167A2 (en) 2024-07-17
US11414391B2 (en) 2022-08-16
WO2019194211A1 (en) 2019-10-10
EP3774745B1 (en) 2024-05-29
CN111902402A (en) 2020-11-06
KR20200139736A (en) 2020-12-14
EA202092393A1 (en) 2021-01-25
US20210147370A1 (en) 2021-05-20
US11840512B2 (en) 2023-12-12
PH12020551605A1 (en) 2021-04-26
MX2020010435A (en) 2020-10-28
SG11202009564TA (en) 2020-10-29
PT3774745T (en) 2024-06-25
JP2022037040A (en) 2022-03-08
IL277730A (en) 2020-11-30
US20220411386A1 (en) 2022-12-29
BR112020019377A2 (en) 2021-01-05
CA3095866A1 (en) 2019-10-10
JP2021517111A (en) 2021-07-15
ZA202006134B (en) 2023-03-29

Similar Documents

Publication Publication Date Title
DK3596042T3 (en) CRYSTAL FORMS OF AMINOLIPIDS
DK3713919T3 (en) CRYSTALLINE FORMS OF N-(4-(4-(CYCLOPROPYLMETHYL)PIPERAZINE-1-CARBONYL)PHENYL)QUINOLINE-8-SULFONAMIDE
DK3279202T3 (en) CRYSTAL OF 3,5-DISUBSTITUTED BENZENALKYNYL COMPOUND
DK3891145T3 (en) MODULATORS OF TREX1
DK3513617T3 (en) Management of PDCP during re-establishment of compound
DK3833662T3 (en) Inhibitors of the protein-protein interaction between KEAP-1-NRF2-
DK3636640T3 (en) CRYSTAL OF HETEROCYCLIDENAACETA MID DERIVATIVE
DK3740475T3 (en) PROCEDURE FOR MANUFACTURE OF SOMATOSTATIN MODULATORS
DK3618758T4 (en) Method for the construction of a dental component
DK3390422T3 (en) CRYSTAL FORMS OF LNT
DK3529236T3 (en) CRYSTAL FORMS OF ERAVACYCLINE
DK3818047T3 (en) Novel compounds for the control of arthropods
DK3927899T3 (en) REDUCTION OF FOUNDATIONS
DK3270823T3 (en) FIXING OF A BONE-CONDUCTING LIQUID MASS MASS TRANSDUCER
DK3833665T3 (en) Diazabicyclooctanones as inhibitors of serine beta-lactamases
DK3765440T3 (en) PROCEDURE FOR THE PREPARATION OF N-ALKYL NITRATOETHYL NITRAMINES
DK3567245T3 (en) OPERATION OF WINDMILLS
DK3856928T3 (en) PROCEDURE FOR CHARACTERIZING MODIFICATIONS CAUSED BY THE USE OF DESIGNER NUCLEASES
DK3743064T3 (en) Treatment of proteinuria
DK3749673T3 (en) Crystalline form of bictegravir sodium
DK3737678T3 (en) Process for the preparation of disubstituted diaryloxybenzoheterodiazole compounds
DK3671200T3 (en) CE-WESTERN APPLICATIONS FOR ANTIBODY DEVELOPMENT
DK3746279T3 (en) CONNECTION OF FORM PARTS
DK3544068T3 (en) PROCEDURE FOR MANUFACTURE OF THERMOELECTRIC MICROCOLDERS
DK3620452T3 (en) Process for the preparation of lenvatinib